We invite researchers to submit abstracts for presentation at the World Congress on Rheumatic Heart Disease.
The Congress provides a unique global platform to share cutting-edge science, innovative clinical practice, and policy-relevant research aimed at advancing prevention, diagnosis, and management of rheumatic heart disease worldwide.
Submissions are being considered for both oral and poster presentation formats, with opportunity for oral presentations to take place during both plenary and symposium sessions within the programme.
Abstracts will be reviewed and scored on a rolling basis. Applicants requesting travel support are strongly encouraged to submit early to allow sufficient time for award notifications and visa application processing, if selected.
KEY DATES
Abstract Submission Deadline: 23:59 AWST, 2 July 2026
Final Notification of Acceptance: 27 July 2026
Late submissions will not be accepted. A late breaking abstract submission window for research completed after the initial deadline will be announced in August.
General ABSTRACTs
Submitted abstracts should align with one of the below themes :
Clinical Research
Research spanning the continuum of care - from primordial and primary prevention to secondary prevention, advanced heart failure management, surgical and transcatheter interventions, including case series and clinical trials.
Group A Strep Vaccines
Research along the full translational spectrum - from antigen discovery and immunopathogenesis to clinical efficacy, safety, and global implementation strategies.
Basic & Translational Science
What new biological insights do we have along the Strep to RHD continuum? How do we convert biological insight into usable clinical tools or interventions?
Health Systems, Programs & Implementation Science
How do we build effective programs, deploy tools strategically, partner well with affected communities and measure country-level progress and impact?
SUBMISSION GUIDELINES
Abstracts must present original research.
Work must not have been previously published in full at the time of submission.
Abstracts must be submitted in English.
Submissions must not exceed 300 words and should adhere to the following structured format (Background, Methods, Results, Conclusions).
Authors must submit through the online abstract portal and select the most appropriate theme during submission (see below).
See full list of frequently asked questions below for more information.
Clinical case ABSTRACTs
About
A limited number of clinical cases will be selected for presentation during dedicated clinical sessions at the congress. These sessions are designed to highlight instructive cases that illustrate important diagnostic challenges, management decisions, or emerging approaches relevant to clinical practice. Submissions should clearly describe the patient presentation, diagnostic evaluation, management, and outcome, while highlighting the aspects that make the case particularly instructive for the clinical community. Early career clinicians are particularly encouraged to submit using this format.
Submissions must not exceed 300 words and should include the following elements:
Brief Clinical Description
A concise summary of the patient presentation, key clinical findings, diagnostic work-up, management, and outcome. Research along the full translational spectrum - from antigen discovery and immunopathogenesis to clinical efficacy, safety, and global implementation strategies.
EDUcational value
A clear explanation of what makes the case unique or particularly important for learning (e.g., unusual presentation, diagnostic challenge, novel management approach, or key clinical lesson).
Major takeaways
Two to three key points that participants should gain from the case discussion.
Clinical imaging
Authors should indicate whether clinical imaging (e.g., echocardiography, ECG or other relevant imaging) is available and can be shared through a secure cloud-based platform for presentation and discussion during the session.
Frequently Asked Questions
-
Yes, submitters can edit their submission (including Title, Content, Authors or Presenting Author) after they have submitted it, up until the submission deadline.
Submitters can do this through their online registration dashboard. Click on the Abstracts tab and then on the “View submission" button to edit the abstract.
-
23:59 AWST, 2 July 2026.
Late submissions will not be accepted.
-
Abstracts will be reviewed and scored on a rolling basis.
Notification of program decisions will come from the Congress Team via email on a rolling basis.
Decisions will also appeared on the submitter’s own ‘dashboard’.
Applicants requesting travel support are strongly encouraged to submit early to allow sufficient time for award notifications and visa application processing, if selected.
Final notifications will be emailed by 27th July 2026.
-
Yes. A late-breaking abstract window for research completed after the initial deadline will be announced in August.
-
Abstracts must:
Present original research
Not have been previously published in full at the time of submission
Be submitted in English
Be 300 words or fewer
Use a structured format oulined above for each General Abstracts & Clinical Case Abstract submissions
Be submitted via the online abstract portal
-
Accepted abstracts may be assigned to:
Oral presentation (plenary session)
Oral presentation (symposium session)
Poster presentation
-
Yes. During submission you can indicate the format you’d like to be considered for.
-
The Scientific Committee, based on peer-review scoring and overall programme balance.
-
Yes. Each author must disclose any relevant financial relationships with providers of commercial products/services discussed, or that supported the CME activity via an educational grant.
-
You must clearly state if a product is off-label for the use described or is investigational.
-
Yes. All accepted abstracts will be published in a special issue of Global Heart and will remain embargoed until publication.